Cargando…
Investigation of the In Vitro Therapeutic Efficacy of Nilotinib in Immortalized Human NF2-Null Vestibular Schwannoma Cells
Vestibular schwannomas (VS) are a common posterior fossa brain tumor, and though benign can cause significant morbidity, particularly loss of hearing, tinnitus, vertigo and facial paralysis. The current treatment options for VS include microsurgical resection, stereotactic radiosurgery or close surv...
Autores principales: | Sabha, Nesrin, Au, Karolyn, Agnihotri, Sameer, Singh, Sanjay, Mangat, Rupinder, Guha, Abhijit, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379978/ https://www.ncbi.nlm.nih.gov/pubmed/22745749 http://dx.doi.org/10.1371/journal.pone.0039412 |
Ejemplares similares
-
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma
por: Au, Karolyn, et al.
Publicado: (2015) -
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
por: Wolf, Amparo, et al.
Publicado: (2011) -
Multiplatform molecular analysis of vestibular schwannoma reveals two robust subgroups with distinct microenvironment
por: Landry, Alexander P., et al.
Publicado: (2023) -
MULTIPLATFORM MOLECULAR ANALYSIS OF VESTIBULAR SCHWANNOMA REVEALS TWO ROBUST SUBGROUPS WITH DISTINCT MICROENVIRONMENT
por: Landry, Alexander P, et al.
Publicado: (2023) -
Identifying Predictors of Early Growth Response and Adverse Radiation Effects of Vestibular Schwannomas to Radiosurgery
por: Larjani, Soroush, et al.
Publicado: (2014)